You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NTLA Sale Disclosure
Leonard John M · SEC Form 4 · Filed Aug 24, 2026
Sale
Calculated transaction value
$36.2K
Leonard John M President And CEO
NTLA
Transaction date
Aug 21, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed 3 days later
NTLA daily price context
Close on/before transaction
$12.84
Aug 21, 2026
First close after public filing
$13.51
Aug 25, 2026
30-day return after filing
-8.73%
Through Sep 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,785 shares @ $13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-363567
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$286.82K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Intellia Therapeutics, Inc. NTLA Current | Sale | Aug 21, 2026 | $36.2K |
| Intellia Therapeutics, Inc. NTLA | Sale | Aug 20, 2026 | $250.61K |